{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:35:45Z","timestamp":1786448145153,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR200059"],"award-info":[{"award-number":["RR200059"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Tech University School of Veterinary Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54898-y","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:13:52Z","timestamp":1780132432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conserved mRNA expression patterns of the Klotho family in canine mammary tumors and human breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Luciana","family":"Kluppel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R. Florke","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Plavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"\u0160vara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Sebastian Solano","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Camila","family":"Hoyos Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimira","family":"Erjavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Emmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Tacer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"\u0160tepihar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia K.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Gomba\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klementina Fon","family":"Tacer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"54898_CR1","unstructured":"Society, A. C. 2026 Estimated New Cancer Cases, (2026). https:\/\/cancerstatisticscenter.cancer.org"},{"key":"54898_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/COC.0b013e3181b8afcf","volume":"33","author":"AD Elias","year":"2010","unstructured":"Elias, A. D. Triple-negative breast cancer: A short review. Am. J. Clin. Oncol. 33, 637\u2013645. https:\/\/doi.org\/10.1097\/COC.0b013e3181b8afcf (2010).","journal-title":"Am. J. Clin. Oncol."},{"key":"54898_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349. https:\/\/doi.org\/10.3322\/caac.21820 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"54898_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto, A. N. et al. Breast cancer statistics 2024. CA Cancer J. Clin. 74, 477\u2013495. https:\/\/doi.org\/10.3322\/caac.21863 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"54898_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.26873\/SVR-2182-2024","volume":"62","author":"K Fon Tacer","year":"2025","unstructured":"Fon Tacer, K. Advancing Cancer Therapies Through the One Health Approach: The Role of Veterinary and Comparative Oncology in Human and Animal Patient Care. Slovenian Veterinary Res. 62, 5\u20137. https:\/\/doi.org\/10.26873\/SVR-2182-2024 (2025).","journal-title":"Slovenian Veterinary Res."},{"key":"54898_CR6","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/jci60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak, K. Heterogeneity in breast cancer. J. Clin. Invest. 121, 3786\u20133788. https:\/\/doi.org\/10.1172\/jci60534 (2011).","journal-title":"J. Clin. Invest."},{"key":"54898_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2017.00227","volume":"4","author":"G Turashvili","year":"2017","unstructured":"Turashvili, G. & Brogi, E. Tumor Heterogeneity in Breast Cancer. Front. Med. (Lausanne). 4, 227. https:\/\/doi.org\/10.3389\/fmed.2017.00227 (2017).","journal-title":"Front. Med. (Lausanne)"},{"key":"54898_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.adcanc.2022.100086","volume":"7","author":"T Tav\u010dar Kunsti\u010d","year":"2023","unstructured":"Tav\u010dar Kunsti\u010d, T., Debeljak, N. & Fon Tacer, K. Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors. Advances in Cancer Biology - Metastasis 100086. https:\/\/doi.org\/10.1016\/j.adcanc.2022.100086 (2023).","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"54898_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/cancers14051253","volume":"14","author":"M Bou Zerdan","year":"2022","unstructured":"Bou Zerdan, M. et al. Triple negative breast cancer: updates on classification and treatment in 2021. Cancers 14, 1253 (2022).","journal-title":"Cancers"},{"key":"54898_CR10","doi-asserted-by":"crossref","unstructured":"Bilani, N., Zabor, E. C., Elson, L., Elimimian, E. B. & Nahleh, Z. Breast cancer in the United States: A Cross-Sectional overview. J Cancer Epidemiol 6387378 (2020). (2020).","DOI":"10.1155\/2020\/6387378"},{"key":"54898_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4048\/jbc.2016.19.3.223","volume":"19","author":"SG Ahn","year":"2016","unstructured":"Ahn, S. G., Kim, S. J., Kim, C. & Jeong, J. Molecular classification of triple-negative breast cancer. J. Breast Cancer 19, 223\u2013230 (2016).","journal-title":"J. Breast Cancer"},{"key":"54898_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/548.6505","volume":"96","author":"F Rastelli","year":"2010","unstructured":"Rastelli, F. et al. Triple-negative breast cancer: Current state of the art. Tumori Journal 96, 875\u2013888 (2010).","journal-title":"Tumori Journal"},{"key":"54898_CR13","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. N. Engl. J. Med. 363, 1938\u20131948 (2010).","journal-title":"N. Engl. J. Med."},{"key":"54898_CR14","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/jci45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750\u20132767. https:\/\/doi.org\/10.1172\/jci45014 (2011).","journal-title":"J. Clin. Invest."},{"key":"54898_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/aac2.12046","volume":"3","author":"AL Sarver","year":"2022","unstructured":"Sarver, A. L., Makielski, K. M., DePauw, T. A., Schulte, A. J. & Modiano, J. F. Increased risk of cancer in dogs and humans: A consequence of recent extension of lifespan beyond evolutionarily-determined limitations?. Aging Cancer 3, 3\u201319. https:\/\/doi.org\/10.1002\/aac2.12046 (2022).","journal-title":"Aging Cancer"},{"key":"54898_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci3010001","author":"FM Lutful Kabir","year":"2015","unstructured":"Lutful Kabir, F. M., Alvarez, C. E. & Bird, R. C. Canine mammary carcinomas: A comparative analysis of altered gene expression. Vet. Sci. https:\/\/doi.org\/10.3390\/vetsci3010001 (2015).","journal-title":"Vet. Sci."},{"key":"54898_CR17","doi-asserted-by":"publisher","unstructured":"Goldschmidt, M. H., Pe\u00f1a, L. & Zappulli, V. Tumors of the mammary gland. Tumors Domest. animals, 723\u2013765, https:\/\/doi.org\/10.1002\/9781119181200.ch17 (2016).","DOI":"10.1002\/9781119181200.ch17"},{"key":"54898_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13028-018-0417-1","volume":"60","author":"I Kaszak","year":"2018","unstructured":"Kaszak, I. et al. Current biomarkers of canine mammary tumors. Acta Vet. Scand. 60, 66. https:\/\/doi.org\/10.1186\/s13028-018-0417-1 (2018).","journal-title":"Acta Vet. Scand."},{"key":"54898_CR19","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jcb.22034","volume":"106","author":"P DeInnocentes","year":"2009","unstructured":"DeInnocentes, P., Agarwal, P. & Bird, R. C. Phenotype-rescue of cyclin\u2010dependent kinase inhibitor p16\/INK4A defects in a spontaneous canine cell model of breast cancer. J. Cell. Biochem. 106, 491\u2013505 (2009).","journal-title":"J. Cell. Biochem."},{"key":"54898_CR20","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/ani10091687","volume":"10","author":"GP Burrai","year":"2020","unstructured":"Burrai, G. P. et al. A statistical analysis of risk factors and biological behavior in canine mammary tumors: a multicenter study. Animals 10, 1687 (2020).","journal-title":"Animals"},{"key":"54898_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.26873\/SVR-2151-2024","volume":"62","author":"T Nikodinovska","year":"2025","unstructured":"Nikodinovska, T. et al. Incidence and types of canine tumours in Slovenia (2000\u20132020): A retrospective study. Slovenian Vet. Res. 62, 27\u201339. https:\/\/doi.org\/10.26873\/SVR-2151-2024 (2025).","journal-title":"Slovenian Vet. Res."},{"key":"54898_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/vco.12603","volume":"18","author":"N Pastor","year":"2020","unstructured":"Pastor, N. et al. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours. Vet. Comp. Oncol. 18, 753\u2013762 (2020).","journal-title":"Vet. Comp. Oncol."},{"key":"54898_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1101\/gr.256388.119","volume":"31","author":"K Graim","year":"2021","unstructured":"Graim, K. et al. Modeling molecular development of breast cancer in canine mammary tumors. Genome Res. 31, 337\u2013347 (2021).","journal-title":"Genome Res."},{"key":"54898_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0300985810393258","volume":"48","author":"M Goldschmidt","year":"2011","unstructured":"Goldschmidt, M., Pe\u00f1a, L., Rasotto, R. & Zappulli, V. Classification and grading of canine mammary tumors. Vet. Pathol. 48, 117\u2013131. https:\/\/doi.org\/10.1177\/0300985810393258 (2011).","journal-title":"Vet. Pathol."},{"key":"54898_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10549-017-4548-2","volume":"167","author":"F Nguyen","year":"2018","unstructured":"Nguyen, F. et al. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: Natural history and prognostic factors. Breast Cancer Res. Treat. 167, 635\u2013648. https:\/\/doi.org\/10.1007\/s10549-017-4548-2 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"54898_CR26","first-page":"146","volume":"80","author":"HW Kim","year":"2016","unstructured":"Kim, H. W. et al. Breed-and age-related differences in canine mammary tumors. Can. J. Vet. Res. 80, 146\u2013155 (2016).","journal-title":"Can. J. Vet. Res."},{"key":"54898_CR27","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.3390\/ijms25052891","volume":"25","author":"N Nosalova","year":"2024","unstructured":"Nosalova, N. et al. Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies. Int. J. Mol. Sci. 25, 2891 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"54898_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci9070357","author":"S Papparella","year":"2022","unstructured":"Papparella, S. et al. Reproducibility and feasibility of classification and national guidelines for histological diagnosis of canine mammary gland tumours: A multi-institutional ring study. Vet. Sci. https:\/\/doi.org\/10.3390\/vetsci9070357 (2022).","journal-title":"Vet. Sci."},{"key":"54898_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00428-008-0644-3","volume":"453","author":"A Gama","year":"2008","unstructured":"Gama, A., Alves, A. & Schmitt, F. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Arch. 453, 123\u2013132 (2008).","journal-title":"Virchows Arch."},{"key":"54898_CR30","doi-asserted-by":"publisher","first-page":"8943","DOI":"10.1007\/s11033-022-07383-4","volume":"49","author":"H Zheng","year":"2022","unstructured":"Zheng, H. et al. The development of molecular typing in canine mammary carcinomas. Mol. Biol. Rep. 49, 8943\u20138951 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"54898_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/modpathol.2010.200","volume":"24","author":"S Badve","year":"2011","unstructured":"Badve, S. et al. Basal-like and triple-negative breast cancers: A critical review with an emphasis on the implications for pathologists and oncologists. Mod. Pathol. 24, 157\u2013167. https:\/\/doi.org\/10.1038\/modpathol.2010.200 (2011).","journal-title":"Mod. Pathol."},{"key":"54898_CR32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fvets.2019.00388","volume":"6","author":"F Chocteau","year":"2019","unstructured":"Chocteau, F., Abadie, J., Loussouarn, D. & Nguyen, F. Proposal for a histological staging system of mammary carcinomas in dogs and cats. Part 1: canine mammary carcinomas. Front. veterinary Sci. 6, 388 (2019).","journal-title":"Front. veterinary Sci."},{"key":"54898_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/vco.12655","volume":"19","author":"F Chocteau","year":"2021","unstructured":"Chocteau, F. et al. One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer. Vet. Comp. Oncol. 19, 140\u2013151 (2021).","journal-title":"Vet. Comp. Oncol."},{"key":"54898_CR34","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2022-0131","volume":"45","author":"BDN Borges","year":"2022","unstructured":"Borges, B. D. N. Epigenetic alterations in canine mammary cancer. Genet. Mol. Biol. 45, e20220131. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2022-0131 (2022).","journal-title":"Genet. Mol. Biol."},{"key":"54898_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.563779","volume":"10","author":"A Amirkhani Namagerdi","year":"2020","unstructured":"Amirkhani Namagerdi, A. et al. Triple-Negative Breast Cancer comparison with canine mammary tumors from light microscopy to molecular pathology. Front. Oncol. 10, 563779. https:\/\/doi.org\/10.3389\/fonc.2020.563779 (2020).","journal-title":"Front. Oncol."},{"key":"54898_CR36","volume-title":"Tumors in domestic animals","author":"DJ Meuten","year":"2020","unstructured":"Meuten, D. J. Tumors in domestic animals (John Wiley & Sons, 2020)."},{"key":"54898_CR37","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2020.548","volume":"5","author":"K Craun","year":"2021","unstructured":"Craun, K. et al. Environmental chemical exposures in the urine of dogs and people sharing the same households. J. Clin. Transl. Sci. 5, e54 (2021).","journal-title":"J. Clin. Transl. Sci."},{"key":"54898_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00617","volume":"10","author":"M Gray","year":"2020","unstructured":"Gray, M. et al. Naturally-occurring canine mammary tumors as a translational model for human breast cancer. Front. Oncol. 10, 617. https:\/\/doi.org\/10.3389\/fonc.2020.00617 (2020).","journal-title":"Front. Oncol."},{"key":"54898_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","volume":"55","author":"JH Oh","year":"2023","unstructured":"Oh, J. H. & Cho, J.-Y. Comparative oncology: Overcoming human cancer through companion animal studies. Exp. Mol. Med. 55, 725\u2013734 (2023).","journal-title":"Exp. Mol. Med."},{"key":"54898_CR40","first-page":"8195","volume":"15","author":"SM Abdelmegeed","year":"2018","unstructured":"Abdelmegeed, S. M. & Mohammed, S. Canine mammary tumors as a model for human disease. Oncol. Lett. 15, 8195\u20138205 (2018).","journal-title":"Oncol. Lett."},{"key":"54898_CR41","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1158\/0008-5472.CAN-14-0392","volume":"74","author":"D Liu","year":"2014","unstructured":"Liu, D. et al. Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer. Cancer Res. 74, 5045\u20135056 (2014).","journal-title":"Cancer Res."},{"key":"54898_CR42","doi-asserted-by":"crossref","unstructured":"Schiffman, J. D. & Breen, M. Comparative oncology: What dogs and other species can teach us about humans with cancer. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 20140231 (2015).","DOI":"10.1098\/rstb.2014.0231"},{"key":"54898_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-020-0297-3","volume":"20","author":"AK LeBlanc","year":"2020","unstructured":"LeBlanc, A. K. & Mazcko, C. N. Improving human cancer therapy through the evaluation of pet dogs. Nat. Rev. Cancer. 20, 727\u2013742. https:\/\/doi.org\/10.1038\/s41568-020-0297-3 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"54898_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s44356-025-00030-7","volume":"2","author":"HF Scheel","year":"2025","unstructured":"Scheel, H. F., Zobolas, J., Lien, T. G., Lingaas, F. & Bergholtz, H. Unraveling prognostic factors in canine mammary gland tumors using machine learning. Vet. Oncol. 2, 16. https:\/\/doi.org\/10.1186\/s44356-025-00030-7 (2025).","journal-title":"Vet. Oncol."},{"key":"54898_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2023.106055","volume":"303","author":"L-M Gherman","year":"2024","unstructured":"Gherman, L.-M., Chiroi, P., Nu\u0163u, A., Bica, C. & Berindan-Neagoe, I. Profiling canine mammary tumors: A potential model for studying human breast cancer. Vet. J. 303, 106055. https:\/\/doi.org\/10.1016\/j.tvjl.2023.106055 (2024).","journal-title":"Vet. J."},{"key":"54898_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o, M. et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45\u201351 (1997).","journal-title":"Nature"},{"key":"54898_CR47","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.1038\/onc.2008.292","volume":"27","author":"I Wolf","year":"2008","unstructured":"Wolf, I. et al. Klotho: A tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene 27, 7094\u20137105 (2008).","journal-title":"Oncogene"},{"key":"54898_CR48","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.18632\/oncotarget.6006","volume":"7","author":"N Tro\u0161t","year":"2016","unstructured":"Tro\u0161t, N. et al. \u03b3Klotho is a novel marker and cell survival factor in a subset of triple negative breast cancers.. Oncotarget 7, 2611\u20132628. https:\/\/doi.org\/10.18632\/oncotarget.6006 (2016).","journal-title":"Oncotarget"},{"key":"54898_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01083","volume":"9","author":"J Su","year":"2019","unstructured":"Su, J. et al. LCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas.. Front. Oncol. 9, 1083 (2019).","journal-title":"Front. Oncol."},{"key":"54898_CR50","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa, I. et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23.. Nature 444, 770\u2013774 (2006).","journal-title":"Nature"},{"key":"54898_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.arr.2008.10.002","volume":"8","author":"Y Wang","year":"2009","unstructured":"Wang, Y. & Sun, Z. Current understanding of klotho. Ageing Res. Rev. 8, 43\u201351 (2009).","journal-title":"Ageing Res. Rev."},{"key":"54898_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80464-5","volume":"14","author":"K Wang","year":"2024","unstructured":"Wang, K., Jiang, Z., Zhou, Q. & Tang, H. The associations between oxidative balance score and serum Klotho level in the US population aged 40\u201379 years.. Sci. Rep. 14, 28909 (2024).","journal-title":"Sci. Rep."},{"key":"54898_CR53","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/antiox12020239","volume":"12","author":"J Donate-Correa","year":"2023","unstructured":"Donate-Correa, J., Mart\u00edn-Carro, B., Cannata-And\u00eda, J. B., Mora-Fern\u00e1ndez, C. & Navarro-Gonz\u00e1lez, J. F. Klotho, oxidative stress, and mitochondrial damage in kidney disease. Antioxidants 12, 239 (2023).","journal-title":"Antioxidants"},{"key":"54898_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00154","volume":"6","author":"N Itoh","year":"2015","unstructured":"Itoh, N., Ohta, H. & Konishi, M. Endocrine FGFs: Evolution, physiology, pathophysiology, and pharmacotherapy.. Front Endocrinol (Lausanne) 6, 154. https:\/\/doi.org\/10.3389\/fendo.2015.00154 (2015).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"54898_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"M Kuro-o","year":"2019","unstructured":"Kuro-o, M. The Klotho proteins in health and disease.. Nat. Rev. Nephrol. 15, 27\u201344. https:\/\/doi.org\/10.1038\/s41581-018-0078-3 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"54898_CR56","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer, K. et al. Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24, 2050\u20132064. https:\/\/doi.org\/10.1210\/me.2010-0142me.2010-0142 (2010). [pii].","journal-title":"Mol. Endocrinol."},{"key":"54898_CR57","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40043","author":"FN Ananya","year":"2023","unstructured":"Ananya, F. N. et al. Neuroprotective role of klotho on dementia. Cureus https:\/\/doi.org\/10.7759\/cureus.40043. 15(6), e40043 (2023).","journal-title":"Cureus"},{"key":"54898_CR58","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu, M. C., Shiizaki, K., Kuro-o, M. & Moe, O. W. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu. Rev. Physiol. 75, 503\u2013533 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"54898_CR59","doi-asserted-by":"publisher","first-page":"117608","DOI":"10.1016\/j.biopha.2024.117608","volume":"180","author":"M Meroni","year":"2024","unstructured":"Meroni, M. et al. \u03b2-Klotho as novel therapeutic target in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A narrative review. Biomed. Pharmacother. 180, 117608 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"54898_CR60","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12882-018-1094-z","volume":"19","author":"D Zou","year":"2018","unstructured":"Zou, D., Wu, W., He, Y., Ma, S. & Gao, J. The role of klotho in chronic kidney disease. BMC Nephrol. 19, 285 (2018).","journal-title":"BMC Nephrol."},{"key":"54898_CR61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2018.02.001","volume":"169","author":"J Fan","year":"2018","unstructured":"Fan, J. et al. The klotho-related protein KLPH (lctl) has preferred expression in lens and is essential for expression of clic5 and normal lens suture formation. Exp. Eye Res. 169, 111\u2013121 (2018).","journal-title":"Exp. Eye Res."},{"key":"54898_CR62","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41388-022-02440-5","volume":"41","author":"H Ligumsky","year":"2022","unstructured":"Ligumsky, H., Merenbakh-Lamin, K., Keren-Khadmy, N., Wolf, I. & Rubinek, T. The role of \u03b1-klotho in human cancer: molecular and clinical aspects. Oncogene 41, 4487\u20134497. https:\/\/doi.org\/10.1038\/s41388-022-02440-5 (2022).","journal-title":"Oncogene"},{"key":"54898_CR63","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1158\/1541-7786.Mcr-15-0141","volume":"13","author":"H Ligumsky","year":"2015","unstructured":"Ligumsky, H. et al. Tumor suppressor activity of Klotho in breast cancer is revealed by structure\u2013function analysis. Mol. Cancer Res. 13, 1398\u20131407. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-15-0141 (2015).","journal-title":"Mol. Cancer Res."},{"key":"54898_CR64","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3892\/ol.2020.11308","volume":"19","author":"K Onishi","year":"2020","unstructured":"Onishi, K. et al. \u03b3-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer. Oncol. Lett. 19, 2306\u20132316. https:\/\/doi.org\/10.3892\/ol.2020.11308 (2020).","journal-title":"Oncol. Lett."},{"key":"54898_CR65","doi-asserted-by":"publisher","first-page":"19508","DOI":"10.18632\/oncotarget.24628","volume":"9","author":"S Hori","year":"2018","unstructured":"Hori, S. et al. Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer. Oncotarget 9, 19508 (2018).","journal-title":"Oncotarget"},{"key":"54898_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/vco.12870","volume":"21","author":"G Kim","year":"2023","unstructured":"Kim, G., Chung, H., Lee, S. & Kim, W. H. Reduced Klotho expression and its prognostic significance in canine hepatocellular carcinoma. Vet. Comp. Oncol. 21, 91\u201399 (2023).","journal-title":"Vet. Comp. Oncol."},{"key":"54898_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265248","volume":"17","author":"H Chung","year":"2022","unstructured":"Chung, H., Lee, S., Kim, G. A. & Kim, W. H. Down-expression of Klotho in canine mammary gland tumors and its prognostic significance. PLoS One 17, e0265248 (2022).","journal-title":"PLoS One"},{"key":"54898_CR68","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/genes16020128","volume":"16","author":"MA Ortega","year":"2025","unstructured":"Ortega, M. A. et al. The Impact of Klotho in Cancer: From Development and Progression to Therapeutic Potential. Genes 16, 128 (2025).","journal-title":"Genes"},{"key":"54898_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav4832","volume":"5","author":"K Fon Tacer","year":"2019","unstructured":"Fon Tacer, K. et al. MAGE cancer-testis antigens protect the mammalian germline under environmental stress. Sci. Adv. 5, eaav4832. https:\/\/doi.org\/10.1126\/sciadv.aav4832 (2019).","journal-title":"Sci. Adv."},{"key":"54898_CR70","unstructured":"Bookout, A. L., Cummins, C. L., Mangelsdorf, D. J., Pesola, J. M. & Kramer, M. F. in Current Protocols in Molecular Biology (John Wiley & Sons, Inc., 2005)."},{"key":"54898_CR71","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp596","volume":"37","author":"D Parkhomchuk","year":"2009","unstructured":"Parkhomchuk, D. et al. Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic Acids Res. 37, e123. https:\/\/doi.org\/10.1093\/nar\/gkp596 (2009).","journal-title":"Nucleic Acids Res."},{"key":"54898_CR72","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods. 5, 621\u2013628. https:\/\/doi.org\/10.1038\/nmeth.1226 (2008).","journal-title":"Nat. Methods"},{"key":"54898_CR73","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295. https:\/\/doi.org\/10.1038\/nbt.3122 (2015).","journal-title":"Nat. Biotechnol."},{"key":"54898_CR74","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"},{"key":"54898_CR75","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/cimb48020139","volume":"48","author":"T Bayat","year":"2026","unstructured":"Bayat, T. et al. Cross-Species Upregulation of MAGED2 in Liver Cancer Suggests a Role in Obesity-Driven Tumor Progression. Curr. Issues. Mol. Biol. 48, 139 (2026).","journal-title":"Curr. Issues. Mol. Biol."},{"key":"54898_CR76","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"54898_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052622","author":"A Bartha","year":"2021","unstructured":"Bartha, A. & Gyorffy, B. TNMplot.com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22052622 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"54898_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052466","author":"MJ Yoo","year":"2024","unstructured":"Yoo, M. J., Jang, Y. J., Park, S. Y., Choi, J. W. & Seol, J. W. Synergistic anti-cancer effects of ERB-041 and Genistein through estrogen receptor suppression-mediated PI3K\/AKT pathway downregulation in canine mammary gland tumor cells. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25052466 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"54898_CR79","doi-asserted-by":"publisher","first-page":"102786","DOI":"10.1016\/j.ctrv.2024.102786","volume":"129","author":"F Papa","year":"2024","unstructured":"Papa, F. et al. Long road towards effective HER3 targeting in breast cancer. Cancer Treat. Rev. 129, 102786. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102786 (2024). https:\/\/doi.org\/https:\/\/doi.org\/","journal-title":"Cancer Treat. Rev."},{"key":"54898_CR80","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1038\/s41467-020-17458-0","volume":"11","author":"TM Kim","year":"2020","unstructured":"Kim, T. M. et al. Cross-species oncogenic signatures of breast cancer in canine mammary tumors. Nat. Commun. 11, 3616. https:\/\/doi.org\/10.1038\/s41467-020-17458-0 (2020).","journal-title":"Nat. Commun."},{"key":"54898_CR81","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.trsl.2011.11.005","volume":"159","author":"SS Pinho","year":"2012","unstructured":"Pinho, S. S., Carvalho, S., Cabral, J., Reis, C. A. & G\u00e4rtner, F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res. 159, 165\u2013172. https:\/\/doi.org\/10.1016\/j.trsl.2011.11.005 (2012).","journal-title":"Transl Res."},{"key":"54898_CR82","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1476-5829.2009.00184.x","volume":"7","author":"KU Sorenmo","year":"2009","unstructured":"Sorenmo, K. U. et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet. Comp. Oncol. 7, 162\u2013172. https:\/\/doi.org\/10.1111\/j.1476-5829.2009.00184.x (2009).","journal-title":"Vet. Comp. Oncol."},{"key":"54898_CR83","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11259-022-09934-3","volume":"47","author":"O Turna","year":"2023","unstructured":"Turna, O. et al. Evidence for heterogeneity in response to treatment in mammary tumors of dogs as happens in humans. Vet. Res. Commun. 47, 111\u2013120. https:\/\/doi.org\/10.1007\/s11259-022-09934-3 (2023).","journal-title":"Vet. Res. Commun."},{"key":"54898_CR84","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","volume":"21","author":"J Sukumar","year":"2021","unstructured":"Sukumar, J., Gast, K., Quiroga, D., Lustberg, M. & Williams, N. Triple-negative breast cancer: promising prognostic biomarkers currently in development. Expert Rev. Anticancer Ther. 21, 135\u2013148 (2021).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"54898_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00238-4","volume":"7","author":"VY Sung","year":"2021","unstructured":"Sung, V. Y. et al. Co-dependency for MET and FGFR1 in basal triple-negative breast cancers. Npj. Breast Cancer 7, 36 (2021).","journal-title":"Npj. Breast Cancer"},{"key":"54898_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30666-0","volume":"13","author":"RC Coombes","year":"2022","unstructured":"Coombes, R. C. et al. Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nat. Commun. 13, 3246. https:\/\/doi.org\/10.1038\/s41467-022-30666-0 (2022).","journal-title":"Nat. Commun."},{"key":"54898_CR87","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/mc.22884","volume":"57","author":"X Zhao","year":"2018","unstructured":"Zhao, X. et al. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression. Mol. Carcinog. 57, 1616\u20131625. https:\/\/doi.org\/10.1002\/mc.22884 (2018).","journal-title":"Mol. Carcinog."},{"key":"54898_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/oncolo\/oyad049","volume":"28","author":"C Dai","year":"2023","unstructured":"Dai, C. & Ellisen, L. W. Revisiting Androgen Receptor Signaling in Breast Cancer. Oncologist 28, 383\u2013391. https:\/\/doi.org\/10.1093\/oncolo\/oyad049 (2023).","journal-title":"Oncologist"},{"key":"54898_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01574-4","volume":"24","author":"EA Kolyvas","year":"2022","unstructured":"Kolyvas, E. A., Caldas, C., Kelly, K. & Ahmad, S. S. Androgen receptor function and targeted therapeutics across breast cancer subtypes. Breast Cancer Res. 24, 79. https:\/\/doi.org\/10.1186\/s13058-022-01574-4 (2022).","journal-title":"Breast Cancer Res."},{"key":"54898_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30071411","author":"V Vidovi\u0107","year":"2025","unstructured":"Vidovi\u0107, V. et al. Androgen receptors in human breast cancer and female canine mammary tumors. Molecules https:\/\/doi.org\/10.3390\/molecules30071411 (2025).","journal-title":"Molecules"},{"key":"54898_CR91","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1200\/JCO.2024.42.16_suppl.1096","volume":"42","author":"RJ Seager","year":"2024","unstructured":"Seager, R. J. et al. Interaction between VEGF-A and immune checkpoint targets in triple-negative breast cancer and mechanisms of immune evasion and tumor progression. J. Clin. Oncol. 42, 1096\u20131096. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.1096 (2024).","journal-title":"J. Clin. Oncol."},{"key":"54898_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104740","volume":"211","author":"R Xu","year":"2025","unstructured":"Xu, R., Guo, S., Song, Q., Wang, X. & Li, Q. PD-1\/PD-L1 inhibitors combined with anti-angiogenic drugs for advanced triple-negative breast cancer: Synergistic mechanisms and research progress. Crit. Rev. Oncol. Hematol. 211, 104740. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104740 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"54898_CR93","doi-asserted-by":"publisher","first-page":"108249","DOI":"10.18632\/oncotarget.22604","volume":"8","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. The implication from RAS\/RAF\/ERK signaling pathway increased activation in epirubicin treated triple negative breast cancer. Oncotarget 8, 108249\u2013108260. https:\/\/doi.org\/10.18632\/oncotarget.22604 (2017).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54898-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54898-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:05:13Z","timestamp":1786446313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54898-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54898"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54898-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The IACUC determined that this study does not require an IACUC-approved protocol since TTU SVM personnel will not be handling animals and only opportunistic samples will be obtained from local practitioners in the course of their routine work.","order":2,"name":"Ethics","label":"Institutional Review Board Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"With informed consent from animals\u2019 owner.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24763"}}